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ABSTRACT 
The carbohydrate recognition domains (CRDs) of the lung collectin surfactant protein D (SP-D) 
recognise sugar patterns on the surface of lung pathogens and promote phagocytosis. Using 
Haemophilus influenzae Eagan strains expressing well-characterised lipopolysaccharide (LPS) 
surface structures of varying complexity we show that bacterial recognition and binding by SP-D 
is inversely related to LPS chain extent and complexity. The crystal structure of a biologically 
active recombinant trimeric SP-D CRD complexed with a delipidated Eagan 4A LPS suggests that 
efficient LPS recognition by SP-D requires multiple binding interactions utilising the three major 
ligand-binding determinants in the SP-D binding pocket, with Ca-dependent binding of inner core 
heptose accompanied by interaction of Kdo with Arg343 and Asp325. Combined with ELISA and 
FACS binding analyses, our results show that extended LPS structures previously thought to be 
targets for collectins are important in shielding more vulnerable sites in the LPS core, revealing a 
mechanism by which pathogens with complex LPS extensions efficiently evade a first-line 
mucosal innate immune defence. The structure also reveals for the first time the dominant form of 
anhydro 3-deoxy-alpha-d-manno-oct-2-ulosonic acid (Kdo).   
 
INTRODUCTION  
The innate immune proteins surfactant protein D (SP-D) and A (SP-A) are pattern recognition 
receptors (PRRs) that belong to the superfamily of collagen containing C-type lectins known as 
the collectins, which in man also includes CL-L1, CL-P1 and mannan-binding lectin (1). 
Collectins can enhance pro-inflammatory molecules like cytokines, and reactive oxygen species in 
phagocytes, by interacting with cell surface receptors or by the scavenging of bacterial molecules 
(2). As first line host defence molecules in the lung, SP-D and SP-A target pathogens for 
neutralisation and rapid clearance through interaction with surface carbohydrate structures and 
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promotion of phagocytosis by alveolar macrophages. Bacterial surface lipopolysaccharide (LPS) 
is a target ligand for immune system defence molecules and recognition by SP-D of various Gram 
negative bacterial LPS, including Escherichia coli (3), Haemophilus influenzae (4,5), Salmonella 
minnesota (3), Bordetella species (6) and Pseudomonas aeruginosa (5), has been reported. Many 
of these studies suggest that lung collectins bind to the LPS core and strongly implicate heptose 
(Hep) and glucose residues in this binding.  
 
H. influenzae is a common cause of human disease worldwide. Serotype b capsular strains cause 
invasive bacteraemic infections such as meningitis and septicaemia (7,8) while the more prevalent 
non-encapsulated or non-typeable H. influenzae strains are a common cause of otitis media (9), 
sinusitis, conjunctivitis and acute lower respiratory tract infections. Surface-expressed LPS is 
involved in each stage of the pathogenesis of infections - colonization of the upper respiratory 
tract, systemic dissemination and cytotoxic injury to target tissues (10). Host molecules that 
recognise the LPS of these organisms are important in limiting pathogenicity. In the newborn and 
young infants innate immune components play a key role in front-line defence against infection, 
while premature infants have reduced collectin levels and are more susceptible to infection (11).  
 
The lipid A region of the LPS of H. influenzae bacteria is linked to a triheptosyl inner core by a 
single phosphorylated keto-deoxyoctulonate (Kdo) moiety. Whilst the LPS glycoform structures 
and the genetic blueprint for biosynthesis are known for many H. influenzae strains, the 
oligosaccharides of the exposed LPS outer core provide substantial heterogeneity within and 
between strains (12,13), hindering detailed investigation of the interaction with the pulmonary 
collectins. The structure of WT H. influenzae strain RM153 (Eagan) LPS (Fig. 1) indicates 
glycose extension from each inner core heptose and a variety of phosphorylated substituents. The 
        Recognition and binding of H. influenzae by SP-D 

rfaF mutant Eagan 4A has a single heptose (HepI) and the orfH deletion mutant CA7 lacks the 
third heptose (HepIII) with the dominant glycoform having no hexose extension off HepII (14).  
 
Structurally collectins are usually multimers of trimers with the number of trimeric units differing 
within the collectin family (15). The C-terminal carbohydrate recognition domain (CRD) mediates 
calcium-dependent binding of microbial cell wall components, the binding affinity increasing 
through multimerisation (15). The separation of the carbohydrate binding sites favours recognition 
of the widely spaced repetitive sugars of microbial cell surfaces over host cell components (16). 
Structural studies of the interaction between human SP-D (hSP-D) and simple ligands have 
utilised a recombinant homotrimeric fragment (rfhSP-D), comprised of the neck region plus three 
CRDs. rfhSP-D retains significant biological activity in vitro and in vivo (17,18), exhibiting 
therapeutic activity in murine models of pulmonary hypersensitivity and infection induced by an 
opportunistic fungus, Aspergillus fumigatus (19). Reported structures of ligand-bound complexes 
are restricted to simple but representative ligands (20-24). Recognition is through CRD Ca-
dependent binding of the terminal monosaccharide through a mannose-type equatorial hydroxyl 
pair or, as for inositol-1-phosphate, galactose and L,D-heptose, a stereochemically equivalent pair. 
 
Based on the reported SP-D recognition of the Gram-negative bacterial LPS core, the well-
characterised H. influenzae strain Eagan LPS and the truncated inner core mutants, representing 
the extreme ends of the spectrum of oligosaccharide content, provide a model to establish the 
structural basis of H. influenzae recognition by the pulmonary collectins in vivo. rfhSP-D, with 
accessible ligand-binding sites in an extensively characterised crystal form, allows determination 
of the role of each component of the inner and terminal LPS core in binding by hSP-D. We report 
here the use of enzyme-linked immunosorbent assays (ELISAs), fluorescence-activated cell 
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sorting (FACS) analysis and x-ray crystallography to study the interactions of hSP-D and rfhSP-D 
with wild type and mutant Eagan bacteria and purified LPS and to demonstrate the functional 
importance of extended LPS structures in evading host collectin-mediated defences. 
 
MATERIALS AND METHODS 
Bacterial strains, culture conditions, and LPS purification. The type b strain RM153 Eagan (7) 
is a disease isolate obtained from the Netherlands (12). Eagan 4A and CA7 are derived mutant 
strains containing kanamycin resistance cassettes that interrupt the rfaF and orfH gene 
respectively, producing truncated LPS glycoforms (14). Before each experiment, bacteria from 
frozen stocks were grown overnight on chocolate agar plates, supplemented with 2 µg/ml 
kanamycin for the mutants. A single colony from the overnight plate was inoculated into 30 ml 
brain heart infusion broth (Oxoid) supplemented with 2 µg/ml NAD and 10 µg/ml haemin 
(Sigma), and kanamycin (10 µg/ml) for mutant strains. Bacteria were grown at 37°C with shaking 
until the desired culture density at 490 nm was reached (OD490 0.6=107 CFU/ml). LPS was 
extracted by the phenol/chloroform/light petroleum method (12) then was purified by repeated 
ultracentrifugation (105 000 g, 4°C, 2 x 5 h). LPS purity was confirmed by SDS-PAGE and 
staining with silver (25). 
 
Purification of human SP-D (NhSP-D). Human SP-D was purified from bronchoalveolar fluid 
obtained by therapeutic saline lung washings of alveolar proteinosis patients from the Royal 
Brompton Hospital, London, using the method of Strong et al. (26). SP-D was passed through a 
Polymyxin B column (Detoxi-Gel, Pierce, UK) to remove endotoxin as previously described (18). 
The final amount of endotoxin present in the SP-D preparations was <0.1 endotoxin units/g 
protein assayed by QCL-1000 Limulus amoebocyte lysate system (BioWhittaker, Walkersville, 
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MD) according to manufacturer's instructions. 
 
Generation and purification of a recombinant fragment of human SP-D. The expression and 
purification of rfhSP-D, a recombinant trimeric neck/CRD fragment of SP-D including a short 
region of the collagen stalk (8 Gly-X-Y) and representing residues 179-355, has been described 
previously (18,19). The contaminating level of endotoxin present in the rhSP-D preparation was 
minimized (18) as for NhSP-D (see above). The assay was linear over a range of 0.1–1.0 EU/ml 
(10 EU=1 ng of endotoxin). 
 
ELISA. The three H. influenzae LPS used were from Eagan wild-type (3 heptoses), Eagan mutant 
CA7 (2 heptoses) and Eagan mutant 4A (1 heptose). The LPS was re-suspended in PBS, 0.5 mM 
ethylenediaminetetraacetic acid (EDTA). Maxisorb 96 well microtitre plates (Nunc) were coated 
with 1 µg LPS /100 µl coating buffer (0.15 M sodium carbonate, 0.35 M sodium bicarbonate) per 
well and incubated overnight at 4°C. Plates were washed three times with tris 
(tris(hydroxymethyl)aminomethane) buffered saline (20 mM Tris, 150 mM NaCl (TBS)) and 
blocked with 150 µl/well blocking buffer (TBS with 2% bovine serum albumin (BSA) (w/v)) at 
room temperature for 2 hours. The plates were washed three times before serial dilutions of 
surfactant proteins were made from 1 µg-10 µg/ 100 µl/well in blocking buffer with 5 mM CaCl2 
or 2 mM EDTA (control). The plates were incubated for 2 hours at room temperature then washed 
with blocking buffer with  5 mM CaCl2 or 2 mM EDTA. Rabbit anti rfhSP-D was diluted 1:1000 
in blocking buffer with 5 mM CaCl2 or 2 mM EDTA and incubated for 2 hours at 37°C, and 
washed four times with blocking buffer with 5 mM CaCl2 or 2 mM EDTA. Goat anti rabbit-Alk 
phosphatase was diluted 1:10,000 in blocking buffer; 100 µl was added per well and incubated for 
2 hours at 37°C. Following four washes with blocking buffer with 5 mM CaCl2 or 2 mM EDTA, 
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colour was developed with 1 mg/ml pNPP (p-nitrophenyl phosphate) diluted in 25 mM Tris-HCl, 
5 mM CaCl2, 5 mM MgCl2 pH 7.4 and read using a plate reader. Sugar competition assays were 
performed by adding maltose at various concentrations to the microtitre plates.  
 
The interactions between collectins and whole bacteria. 30 ml cultures of H. influenzae were 
grown to 107 CFU/ml as described earlier. The bacteria were pelleted then washed three times 
with TBS (20 mM tris, 150 mM NaCl, pH 7.4). The final pellet was re-suspended in TBS/C (TBS 
with 2 mM CaCl2), containing either 10 µg/ml of biotinylated collectins or BSA (control), and 
incubated for 30 minutes on ice. After pelleting and washing three times, bacteria were incubated 
with streptavidin-phycoerythrin for 30 minutes on ice. The samples were washed and fixed in 4% 
(v:v) paraformaldehyde before being analysed by flow cytometry.  
 
FITC labelling of bacteria. 1 mg FITC (Sigma) was dissolved in 1 ml of pH 9.6 buffer (1 M 
NaHCO3 (pH 8.2) adjusted to pH 9.6 with 1 M Na2CO3 (pH 11.6)) to make a stock solution which 
was diluted 10-fold for labelling the bacteria. Bacteria grown overnight were diluted into fresh 
media the following day until the desired OD was reached. The bacteria were washed twice in 
PBS and then re-suspended with 1ml FITC (100 ug/ml) solution and incubated for 1 hour at room 
temperature. Unbound FITC was removed by washing twice with PBS. The FITC labelled 
bacteria pellet was re-suspended in storage buffer and stored at 20°C. Viability was verified 
through plating. 
 
Statistical analysis. Means and standard deviations  were calculated by GraphPad Prism (Version 
6)  software  and p-values for the differences between means were determined by the student t-test 
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(unless otherwise stated) with equal variance. Results were considered significant if the p value 
was <0.05. 
 
Preparation of Eagan 4A core oligosaccharide for crystallographic study. Mild acid 
hydrolysis was carried out on both Eagan wild type and Eagan 4A LPS based on the procedure 
described by Masoud et al. (12). Starting LPS was 53 mg for 4A; 50 mg for wild type, giving 
yields of 18 mg LPS core, yield ~80% for 4A; 30 mg, ~90% for wild type. 
 
Crystallization and data collection. Native crystals of rfhSP-D were grown and cryoprotected as 
described previously (23,24). Buffers for cryocooling and ligand soaking were prepared by 
addition of LPS oligosaccharide to cryobuffers prepared using MPD (2,4-methylpentane diol) in 
precipitant buffer to provide a final concentration of ligand within the cryobuffer of 30 mM. Data 
were collected at 100°K on an ADSC Quantum 4R CCD detector on Daresbury SRS station 14.1 
(λ = 1.488 Å). Integrated intensities were calculated with the program MOSFLM (27). 
 
Structure solution and refinement. Isomorphism was sufficient to allow the coordinates of the 
1.6 Å native rfhSP-D structure (pdb id 1PW9 (23)) to be used as a starting model for the rfhSP-D 
- Eagan 4A oligosaccharide complex. Electron density maps were calculated using CNS (28) and 
the CCP4 program suite (29) including density modification (solvent flattening and histogram 
matching, but not NCS averaging). Model building was carried out using maximum likelihood 
refinement with CNS (28) alternated with rounds of manual model building with the program O 
(30). Ligand topology and parameter files were obtained from the HIC-Up server (31). Final 
refinement details are given in Table 1 and the quality of the final structure was verified by 
MolProbity (32) and PROCHECK (33). All main and side chain stereochemical parameters fall 
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either inside or are better than those expected (PROCHECK) with 98% of residues in favoured 
regions of the Ramachandran plot, with no outliers. Molecular figures were generated using 
MOLSCRIPT (34) and the PyMOL Molecular Graphics System Version 1.4 (Schrödinger, LLC, 
2011). Coordinates and structure factors have been deposited in the Protein Data Bank with 
accession code 4E52. 
 
RESULTS  
The binding of hSP-D to H. influenzae Eagan LPS. The interactions of native hSP-D (NhSP-D) 
and rfhSP-D with LPS from H. influenzae were investigated by ELISA. NhSP-D binding to Eagan 
4A was concentration (< 1 µg/ml, p < 0.05; >1 µg/ml, p< 0.001 (Fig. 2a)) and calcium dependent, 
substitution of the 2 mM calcium buffer with 5 mM EDTA (ethylenediaminetetraacetic acid) 
buffer resulting in no detectable binding (data not shown). NhSP-D bound more efficiently to LPS 
from mutant strains of bacteria expressing fewer heptoses in their core region (CA7 p<0.01, 4A 
p<0.001) than the LPS from Eagan wild-type bacteria (Fig. 2a). The relative binding affinity of 
NhSP-D for LPS was 4A (1 Heptose) >> CA7 (2 Heptoses) > WT (3 Heptoses). Addition of 100 
mM maltose completely inhibited the binding of NhSP-D to the wild-type LPS (Fig. 2a) but only 
partially inhibited binding to Eagan 4A LPS  (~40% reduction at >5 µg/ml, p<0.01 (Fig. 2c)).  
 
Similarly, rfhSP-D bound much more strongly to Eagan 4A than either Eagan CA7 or Eagan wild-
type LPS (p<0.001 (Fig. 2b)). This interaction with Eagan 4A was completely inhibited by EDTA 
(data not shown) and was rfhSP-D concentration dependent (>1 µg/ml, p< 0.001). Binding of both 
wild-type and CA7 LPS by rfhSP-D was seen at a concentration of 5 µg/ml (p<0.01, compared to 
0 µg/ml). The binding was also shown to be inhibited by maltose in a dose dependent manner, 
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serial dilution showing that 25 mM maltose was sufficient for significant inhibition (p<0.05 (Fig. 
2d)) with complete inhibition in the presence of 100 mM maltose (Fig. 2b, 2d). 
  
The binding of hSP-D to whole bacteria. We investigated using FACS whether the binding of 
NhSP-D and rfhSP-D to isolated LPS was reflected in their interactions with different strains of 
whole bacteria. Consistent with the ELISA findings, NhSP-D bound more efficiently to both 
Eagan 4A and Eagan CA7 mutant bacteria than to wild-type strain Eagan (Fig. 2e). However, the 
binding of rfhSP-D to Eagan 4A was markedly more efficient than that to WT and CA7 (Fig. 2f). 
Binding was inhibited by maltose and abrogated in the presence of EDTA (data not shown). 
 
Crystal structure. Data collection and processing statistics are given in Table 1. Since data from 
all rfhSP-D crystals soaked with the wild type LPS oligosaccharide failed to reveal bound sugar in 
the ligand binding site, only results for the 4A ligand are presented here. The crystal structure of 
rfhSP-D complexed with the Eagan 4A core saccharide isolated from Eagan 4A LPS reveals Ca-
dependent binding of the ligand via the Kdo (3-deoxy-D-manno-octulosonic acid) -linked inner 
core heptose (HepI) utilising the O6' and O7' hydroxyls of HepI (Fig. 3a). The electron density 
reveals bound saccharide in only two of the three CRDs with ligand absent in chain A.  
 
The electron density map shows no density for the β1-4 glucose attached to HepI. While there is 
clear density for the α1-5 Hep – Kdo glycosidic bond, the density of the attached sugar suggests a 
closed 5-membered ring rather than the expected Kdo pyranose ring. The best fit to this density 
(Fig. 3b) is a modified ribose ring with side groups placed according to the density, agreeing with 
the proposed enantiomeric furanoid derivative (Fig. 4) resulting from mild acid hydrolysis of O5-
substituted Kdo (35). The Kdo C4 enantiomeric substitution is not visible in the electron density 
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although there is evidence of either or both enantiomeric positions of O2' (original Kdo 
numbering) in a position which suggests interaction with Arg343 (Fig. 3b). The modified Kdo is 
positioned towards Asp325 and Arg343, with hydrogen bonds between Asp325 and one of the 
hydroxyl groups (Fig. 5). On one side of the binding pocket the residues Asn323 and Asp325 are 
positioned similarly to those in the mannobiose and inositol phosphate structures; on the opposite 
side Arg343 is tilted towards the Hep as in the galactose-bound structure where hydrogen bonds 
between the galactose and Arg343 are formed (24).  
 
DISCUSSION  
The interactions between lung surfactant protein D and H. influenzae strain Eagan have been 
investigated in vitro by a variety of techniques using whole bacteria and isolated LPS. Studies of 
binding in vitro, complemented by resolution of the three dimensional structure of the rfhSP-D 
complex with Eagan 4A core oligosaccharide, combine to give a consistent and compelling 
picture of recognition by SP-D being inversely related to LPS complexity. Recognition of the 
Eagan 4A LPS core by the SP-D CRD is mediated through calcium-dependent binding of HepI 
enhanced by additional interactions between the HepI-Kdo core and the ligand-binding 
determinants Asp325 and Arg343 which flank the ligand-binding pocket of the protein. 
 
Both native hSP-D (NhSP-D) and the biologically active (17-19) recombinant trimeric fragment 
rfhSP-D bind weakly to LPS from WT Eagan and the mutant strain CA7, but bind more avidly to 
Eagan 4A LPS which has a more truncated core with fewer heptoses (Fig. 2a, 2b). In all cases 
binding is calcium-dependent and completely inhibited by EDTA. While maltose inhibition of 
LPS binding appears to differ significantly between NhSP-D and rfhSP-D (Fig. 2a, 2c, 2d), this is 
not the case as 100 mM maltose for NhSP-D (Fig. 2c) is equivalent to ~15 mM maltose for rfhSP-
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D (Fig. 2d) in terms of the molar excess of maltose over CRD. The binding of both forms of SP-D 
to whole bacterial cells (Fig. 2e, 2f) shows the same pattern as isolated LPS, binding efficiently to 
Eagan 4A bacteria but less so, particularly for rfhSP-D, to the WT and CA7 strains. NhSP-D, but 
not rfhSP-D, binding to Eagan WT and CA7 relative to 4A appears to be markedly more efficient 
for whole bacteria than isolated LPS. This may reflect the LPS pattern on the bacterial surface 
rather than fixed on ELISA plates, allied to the broader repertoire of pattern recognition of the 
oligomerised NhSP-D, allowing efficient multiple binding of LPS targets on the bacterial surface.  
 
The NhSP-D and rfhSP-D binding studies with both bacteria and isolated LPS suggest that the 
preferred interaction of SP-D with Haemophilus Eagan strains is calcium mediated CRD binding 
to the LPS proximal core region rather than the distal core terminal sugars (3), the more extended 
LPS structures of the WT and CA7 bacteria interfering with this recognition. The crystal structure 
(see below) confirms that hSP-D binds this preferred, inner core target when it is exposed as in 
Eagan 4A. Both NhSP-D and rfhSP-D may, however, target the terminal core sugars when the 
inner core is shielded as in the WT and CA7 strains although the binding studies suggest that only 
NhSP-D is able to accomplish the multimeric binding required for significant attachment.  
 
The crystal structure of rfhSP-D complexed with Eagan 4A oligosaccharide reveals Ca-dependent 
ligand binding via the HepI O6' and O7' hydroxyls of the Kdo-linked inner core heptose HepI, 
despite the availability of mannose-type O3', O4' pairs (24) on HepI and the HepI terminal Glc. 
HepI shows a significant rotation away from Asp325 (Fig. 5) when compared to the bound Hep in 
the heptose disaccharide bound rfhSP-D structure (22). The β1-4 Glc attached to HepI O4 is not 
visible in the electron density, presumably due to conformational freedom about the glycosidic 
linkage and a lack of constraining protein or crystal contacts. There is clear electron density for 
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the α1-5 Hep – Kdo glycosidic bond but the Kdo electron density does not resemble a pyranose 
ring. Previous analyses of hydrolysed H. influenzae LPS consistently indicate uncharacterised 
anhydro Kdo forms (12,25,36). The best fit to the electron density (Fig. 3b) is the proposed (35) 
5-membered anhydro Kdo ring arising from -elimination of phosphate or pyrophosphate from 
KdoO4, accompanied by pyranose ring opening (35,37) and subsequent 4,7 ring closure to form a 
furanoid derivative with a chiral centre at C4 carrying an extended substitution (Fig. 4). Density 
for the C4 substituents is absent except in a position (Fig. 3b) which may correspond to either or 
both of the enantiomeric positions of O2' (original Kdo numbering, Fig. 4). This demonstrates for 
the first time the putative structure of the dominant anhydro Kdo formed by the hydrolysis 
procedures used in the characterisation of a variety of bacterial LPS.   
 
Asp325 is hydrogen-bonded to the KdoC6 OH group, which would be similarly positioned in a 
normal Kdo oriented similarly with respect to HepI (Fig. 5). Crucially, C4 in the anhydro Kdo is 
positioned such that normal Kdo would present the C4 phosphate to Arg343. Alternatively, 
rotation of the normal Kdo about the glycosidic α1-5 HepI-Kdo bond would direct the KdoC7 and 
C8 OH groups towards Asp325 and the acidic group off KdoC2 towards Arg343. This position of 
the normal Kdo acidic group aligns with the isolated density seen here off the anhydro KdoC4 
(Fig. 3b). Thus, recognition of the Eagan 4A inner core involves not only the primary calcium ion 
but also both binding site flanking residues (20-24). This concerted binding suggests high affinity 
for the HepI-Kdo disaccharide, consistent with the binding studies where Eagan 4A competes 
strongly with the high affinity SP-D ligand maltose. This optimal mode of SP-D binding via the 
inner core is consistent with studies of Bordetella mutants (6) and S. minnesota strains with 
incomplete cores (3), while mannose binding protein binds to Hep and GlcNAc in the rough core 
oligosaccharide of the E. coli K-12 cell wall, and to Hep in the incomplete core of E. coli B (38). 
        Recognition and binding of H. influenzae by SP-D 

 
The reduced affinity of SP-D for Eagan CA7, both bacteria and purified LPS, compared to Eagan 
4A is at first sight puzzling since the dominant CA7 glycoform lacks any hexose extension off 
HepII (14). The additional substituted sugar off HepI (HepII at O3') for CA7, in addition to Kdo 
and Glc at O4', will introduce steric constraints which may affect the ability of HepI, and hence 
Kdo, to achieve the preferred high affinity, multiple protein and LPS interactions demonstrated by 
the structure presented here. The weak affinity of rfhSP-D for the Eagan CA7 and WT LPS may 
then arise from alternative recognition such as the terminal glucose or the O3', O4' pair on HepII. 
 
A picture thus emerges of enhanced bacterial resistance to SP-D through expression of extended 
LPS glycoforms, the crystal structure revealing that optimal binding is achieved through multiple 
interactions of the inner core HepI-Kdo pair with all three major ligand-binding determinants in 
the SP-D binding pocket. If this optimal binding is precluded by the spatial and conformational 
constraints of additional sugars, recognition may still be achieved through other hydroxyl pairs, 
although there is a clear inverse relationship between binding and LPS complexity.  
 
The enhanced binding of the mutant with exposed core targets for the SP-D CRD demonstrates 
the efficiency of recognition in the absence of more complex LPS structures, with considerable 
selective pressure on the bacterium to develop such structures to shield these vulnerable sites and 
subvert SP-D mediated host defences, as is the case for the more resistant WT Eagan strains. 
Strategies designed to disrupt LPS synthesis in Haemophilus and other Gram-negative organisms 
could thus be effective in rendering bacteria susceptible to host innate immune defences mediated 
by collectins. Whether rfhSP-D can act as an opsonin for strains with truncated LPS cores is not 
clear from the results presented here, but the potential of high doses of the recombinant fragment 
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to enhance bacterial clearance is worthy of further investigation, since Eagan 4A bacteria and 
isolated LPS are recognised and bound by SP-D even in the absence of the collagen tail and N-
terminal region, and the multimeric binding potential, of the native oligomer. 
 
The current studies demonstrate a potential general mechanism by which Gram-negative bacteria 
have evolved extended LPS structures to escape innate immune surveillance by collectins. 
Increasing LPS complexity may have provided selective pressure for the recombination of host 
genes encoding non-fibrillary collagens and CRDs (39), enabling multimerisation and increased 
avidity for complex LPS structures on the surface of pathogens. This may represent a model 
demonstrating how microbial and host genes have co-evolved. 
 
FUNDING INFORMATION 
This work was supported by the Medical Research Council (AKS, TJG, KBMR, HWC, DWH, 
MED), CLRC Daresbury Laboratory (TJG, AKS), STFC (TJG, AKS), Diamond Light Source 
(TJG, AKS), the Sir Halley Stewart Trust (HWC) and the Beit Memorial Fellowships (HWC). 
 
ACKNOWLEDGEMENTS 
Help from the beamline scientists at the Daresbury SRS and the Diamond Light Source is 
gratefully acknowledged. 
 




1. Holmskov UL. 2000. Collectins and collectin receptors in innate immunity. APMIS 
Supplement 100:1-59. 
2. Sano H, Kuroki Y. 2005. The lung collectins, SP-A and SP-D, modulate pulmonary innate 
immunity. Molecular Immunology 42:279-287. 
3. Kuan SF, Rust K, Crouch E. 1992. Interactions of Surfactant Protein-D with Bacterial 
Lipopolysaccharides - Surfactant Protein-D is an Escherichia-Coli Binding-Protein in 
Bronchoalveolar Lavage. Journal of Clinical Investigation 90:97-106. 
4. LeVine AM, Whitsett JA, Gwozdz JA, Richardson TR, Fisher JH, Burhans MS, 
Korfhagen TR. 2000. Distinct Effects of Surfactant Protein A or D Deficiency During 
Bacterial Infection on the Lung. J Immunol 165:3934-3940. 
5. Restrepo CI, Dong Q, Savov J, Mariencheck WI, Wright JR. 1999. Surfactant Protein D 
Stimulates Phagocytosis of Pseudomonas aeruginosa by Alveolar Macrophages. Am J Respir 
Cell Mol Biol 21:576-585. 
6. Schaeffer LM, McCormack FX, Wu H, Weiss AA. 2004. Interactions of pulmonary 
collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharides 
elucidate the structural basis of their antimicrobial activities. Infection and Immunity 72:7124-
7130. 
7. Moxon RE, Vaughn KA. 1981. The Type b Capsular Polysaccharide as a Virulence 
Determinant of Haemophilus influenzae: Studies Using Clinical Isolates and Laboratory 
Transformants. J Infectious Diseases 143:517-524.  
8. Moxon ER, Maskell D. 1992. Haemophilus influenzae lipopolysaccharide: the biochemistry 
and biology of a virulence factor. In Molecular Biology of Bacterial Infection: Current Status 
        Recognition and binding of H. influenzae by SP-D 
	
and Future Perspectives (Harmaeche CE, Penn CW, Smyth CJ: eds), pp. 75-96. Cambridge 
University Press, Cambridge, UK. 
9. Murphy TF, Apicella MA. 1987. Nontypable Haemophilus influenzae: A Review of Clinical 
Aspects, Surface Antigens, and the Human Immune Response to Infection. Reviews of 
Infectious Diseases 9:1-15. 
10. Moxon ER. 1985. The molecular basis of Haemophilus influenzae virulence. J R Coll 
Physicians London 19:174-178. 
11. Malhotra R, Willis AC, Lopez Bernal A, Thiel S, Sim RB. 1994. Mannan-binding protein 
levels in human amniotic fluid during gestation and its interaction with collectin receptor from 
amnion cells. Immunology 82:439-444. 
12. Masoud H, Moxon ER, Martin A, Krajcarski D, Richards JC. 1997. Structure of the 
variable and conserved lipopolysaccharides oligosaccharide epitopes expressed by 
Haemophilus influenzae serotype b strain Eagan. Biochemistry 36:2091–2103. 
13. Hood DW, Richards JC, Moxon ER. 1999. Haemophilus influenzae lipopolysaccharide. 
Biochem Soc Trans 4:493-498. 
14. Hood DW, Deadman ME, Allen T, Masoud H, Martin A, Brisson JR, Fleischmann R, 
Venter JC, Richards JC, Moxon ER. 1996. Use of the complete genome sequence 
information of Haemophilus influenzae strain Rd to investigate lipopolysaccharides 
biosynthesis. Mol Microbiol 22:951-965. 
15. Crouch EC. 1998. Structure, biologic properties, and expression of surfactant protein D (SP-
D). Biochimica et Biophysica Acta 1408:278-289. 
16. Weiss WI, Drickamer K. 1996. Structural basis of lectin-carbohydrate recognition. Annual 
Review of Biochemistry 65:441-473. 
17. Clark HW, Reid KBM. 2002. Structural requirements for SP-D function in vitro and in vivo: 
        Recognition and binding of H. influenzae by SP-D 


Therapeutic potential of recombinant SP-D. Immunobiology 205:619-631. 
18. Singh M, Madan T, Waters P, Parida SK, Sarma PU, Kishore U. 2003. Protective effects 
of a recombinant fragment of human surfactant protein D in a murine model of pulmonary 
hypersensitivity induced by dust mite allergens. Immunology Letters 86:299-307. 
19. Madan T, Kishore U, Singh M, Strong P, Clark HW, Hussain EM, Reid KBM, Sarma 
PU. 2001. Surfactant proteins A and D protect mice against pulmonary hypersensitivity 
induced by Aspergillus fumigatus antigens and allergens. J Clin Invest 107:467-475. 
20. Crouch E, Hartshorn K, Horlacher T, McDonald B, Smith K, Carafella T, Seaton B, 
Seeberger PH, Head J. 2009. Recognition of mannosylated ligands and influenza A virus by 
human surfactant protein D: contributions of an extended site and residue 343. Biochemistry 
48:3335–3345. 
21. Crouch E, McDonald B, Smith K, Roberts M, Mealy T, Seaton B, Head J. 2007. Critical 
role of Arg/Lys343 in the species-dependent recognition of phosphatidylinositol by pulmonary 
surfactant protein D. Biochemistry 46:5160–5169. 
22. Wang H, Head J, Kosma P, Brade H, Muller-Loennies S, Sheikh S, McDonald B, Smith 
K, Cafarella T, Seaton B, Crouch E. 2008. Recognition of heptoses and the inner core of 
bacterial lipopolysaccharides by surfactant protein D. Biochemistry 47:710–720. 
23. Shrive AK, Tharia HA, Strong P, Kishore U, Burns I, Rizkallah PJ, Reid KBM, 
Greenhough TJ. 2003. High resolution structural insights into ligand binding and immune 
cell recognition by human lung surfactant protein D. J Mol Biol 331:509–523. 
24. Shrive AK, Martin C, Burns I, Paterson JM, Martin JD, Townsend JP, Waters P, Clark 
HW, Kishore U, Reid KBM, Greenhough TJ. 2009. Structural characterisation of ligand-
binding determinants in human lung surfactant protein D: influence of Asp325. J Mol Biol 
394:776-788. 
        Recognition and binding of H. influenzae by SP-D 

25. Deadman ME, Hermant P, Engskog M, Makepeace K, Moxon ER, Schweda EKH, Hood 
DW. 2009. Lex2B, a phase-variable glycosyltransferase, adds either a glucose or a galactose 
to Haemophilus influenzae Lipopolysaccharide. Infection and Immunity 77:2376-2384. 
26. Strong P, Kishore U, Morgan C, Lopez Bernal A, Singh M, Reid KBM. 1998. A novel 
method of purifying lung surfactant proteins A and D from the lung lavage of alveolar 
proteinosis patients and from pooled amniotic fluid. J Immunol Methods 1:139-149. 
27. Leslie AGW. 1992. Recent changes to the MOSFLM package for processing film and image 
plate data. Joint CCP4 and ESF-EACMB Newsletter on Protein Crystallography 26. 
Daresbury Laboratory, Warrington, UK. 
28. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang 
JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. 
1998. Crystallography and NMR System: a new software suite for macromolecular structure 
determination. Acta Cryst D54:905-921. 
29. Collaborative Computational Project Number 4. 1994. The CCP4 suite: programs for 
protein crystallography. Acta Cryst D50:760-763. 
30. Jones TA, Zou JY, Cowan SW, Kjeldgaard M. 1991. Improved methods for building 
protein models in electron density maps and the location of errors in these models. Acta Cryst 
A47:110-119. 
31. Kleywegt GJ, Henrick K, Dodson EJ, van Aalten DMF. 2003. Pound-wise but penny-
foolish - How well do micromolecules fare in macromolecular refinement? Structure 11:1051-
1059. 
32. Chen VB, Arendall III WB, Headd JB, Keedy DA, Immormino RM, Kapral GJ, Murray 
LW, Richardson JS, Richardson DC. 2010. MolProbity: all-atom structure validation for 
macromolecular crystallography. Acta Cryst D66:12-21. 
        Recognition and binding of H. influenzae by SP-D 

33. Laskowski R, MacArthur MW, Moss DS, Thornton JM. 1993. PROCHECK: a program to 
check the stereochemical quality of protein structures. J Appl Crystallogr 26:283-291. 
34. Kraulis PJ. 1991. MOLSCRIPT: A program package to produce both detailed and schematic 
plots of protein structures. J Appl Cryst 24:946. 
35. Auzanneau F-I, Charon D, Szabó L. 1991. Phosphorylated sugars. Part 27. Synthesis and 
reactions, in acid medium, of 5-O-substituted methyl 3-deoxy-α-D-manno-oct-2-
ulopyranosidonic acid 4-phosphates. J Chem Soc Perkin Trans 1:509–517. 
36. Yildirim HH, Hood DW, Moxon ER, Schweda EKH. 2003. Structural analysis of 
lipopolysaccharides from Heamophilus influenzae serotype f: structural diversity observed in 
three strains. Eur J Biochem 270:3153-3167. 
37. Danan A, Mondange M, Sarfati SR, Szabo P. 1982. Synthesis and behaviour under acidic 
conditions of 2-deoxy-D-arabino-hexopyranose and 3-deoxy-2-ketoaldonic acids bearing O-
phosphono or O-glucosyl substituents at position  to the carbonyl function. J Chem Soc 
Perkin Trans 1:1275-1282. 
38. Kawasaki N, Kawasaki T, Yamashina I. 1989. A serum lectin (mannan-binding protein) has 
complement-dependent bactericidal activity. J Biochem 106:483-489. 
39. Bezouska K, Crichlow GV, Rose JM, Taylor ME, Drickamer K. 1991. Evolutionary 
conservation of intron position in a subfamily of genes encoding carbohydrate-recognition 
domains. J Biol Chem 266:11604-11609. 
        Recognition and binding of H. influenzae by SP-D 

FIGURE LEGENDS 
Figure 1. Schematic representation of LPS isolated from wild type and mutant H. influenzae 
RM153 (Eagan) strains (adapted from (14)). The relevant sugar links formed by the orfH and rfaF 
gene products are shown by arrows, Eagan CA7 and Eagan 4A referring to the orfH and rfaF 
mutant strains respectively. The dominant orfH mutant has no glycoside extension off HepII. 
Indicated in the figure are Glc, glucose; Gal, galactose; Hep, heptose; Kdo, 3-deoxyoctulosonic 
acid; PC, phosphocholine; P, phosphate; PE, phosphoethanolamine.  
Figure 2. SP-D interactions with H. influenzae Eagan wild-type and mutant strains of isolated 
LPS and whole bacteria. Error bars represent SD, Students t test, P values *p<0.05, **p<0.01, 
***p<0.001. (a), (b) interactions of (a) native hSP-D, (b) recombinant SP-D with H. influenzae 
LPS. (c), (d) Sugar competition assays with Eagan 4A LPS (c) native hSP-D, (d) recombinant SP-
D. (e), (f) FACS analysis of binding of whole bacteria by (e) native hSP-D (f) recombinant SP-D. 
Figure 3. Bound Eagan 4A in subunit B of the rfhSP-D – ligand complex. (a) The coordination of 
the calcium ion Ca1 and HepI (b) Stereo electron density for the bound Glc-Hep and the putative 
Kdo(anhydro) ligand. Original Kdo numbering retained. Density labelled A corresponds to the 
putative position of O2' (original Kdo numbering) in either or both of the enantiomeric 
substituents off KdoC4. The glucose is not visible in the electron density. 
Figure 4. Formation of the 4,7 closure furanoid derivative (anhydro Kdo) following mild acid 
hydrolysis and β-elimination of the phosphate from O4 of Kdo. Original Kdo numbering retained. 
Adapted from (35).  
Figure 5. The Hep-Kdo(anhydro) disaccharide in the ligand binding site. Kdo O6' is positioned to 
interact with Asp325, while the enantiomeric C4 substituent is not identifiable in the electron 
density except for an indication of O2' (original Kdo numbering), directed towards Arg343, which 
may be similarly positioned in both enantiomers. Original Kdo numbering retained.
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Table 1. Data collection and processing 
Data collection   
Synchrotron station  SRS 14.1 
Wavelength (Å)  1.488 
Space group   P21 
Cell dimensions   a=55.35 Å, b=107.99 Å, c=55.65Å, α= 90°, β=92.14°, γ=90° 
Maximal resolution (Å)   1.70 
Highest resolution bin (Å)  1.79-1.70 
Observations   217,593 (31,047) 
Unique reflections   71,591 (10,454) 
Completeness (%)   99.9 (99.9) 
Rmerge a   0.075 (0.295) 
I/σ(I)   5.1 (2.4)   
Refinement   
Protein atomsb  3483 
 Residues chain A, B, C   204-355 
Water molecules  531 
Calcium ions  9 
Ligand atoms  44 
Rwork c (%)   19.2 
Rfree d (%)   21.0 
r.m.s.d. bond length (Å)  0.007 
r.m.s.d. bond angle (°)  1.2 
Average B-values (Å2) 
 Protein main chain  21.6 
 Water  33.3 
 Other hetero-atoms  29.4 
Ramachandran plot values e (%)  
 Favoured  98.0 
 Outliers  0.0 
Figures in parentheses refer to the highest resolution bin 
a
 Rmerge = ΣhΣj |Ih,j - Ih| /ΣhΣj |Ih,j| , where Ih,j is the jth observation of reflection h and Ih is the mean of the j 
measurements of reflection h 
b
 Excluding alternative side-chain conformations 
c
 Rwork = Σh ||Foh| - |Fch|| /Σh |Foh| , where Foh and Fch are the observed and calculated structure factor 
amplitudes, respectively, for the reflection h.  
d
 Rfree is equivalent to Rwork for a randomly selected subset (5%) of reflections not used in the refinement. 
e
 Defined according to Molprobity 
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Figure 1. Schematic representation of LPS isolated from wild type and mutant H. influenzae 
RM153 (Eagan) strains (adapted from (14)). The relevant sugar links formed by the orfH and rfaF 
gene products are shown by arrows, Eagan CA7 and Eagan 4A referring to the orfH and rfaF 
mutant strains respectively. The dominant orfH mutant has no glycoside extension off HepII. 
Indicated in the figure are Glc, glucose; Gal, galactose; Hep, heptose; Kdo, 3-deoxyoctulosonic 
acid; PC, phosphocholine; P, phosphate; PE, phosphoethanolamine.  
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Figure 2. SP-D interactions with H. influenzae Eagan wild-type and mutant strains of isolated 
LPS and whole bacteria. Error bars represent SD, Students t test, P values *p<0.05, **p<0.01, 
***p<0.001. (a), (b) interactions of (a) native hSP-D, (b) recombinant SP-D with H. influenzae 
LPS. (c), (d) Sugar competition assays with Eagan 4A LPS (c) native hSP-D, (d) recombinant SP-
D. (e), (f) FACS analysis of binding of whole bacteria by (e) native hSP-D (f) recombinant SP-D. 
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Figure 3. Bound Eagan 4A in subunit B of the rfhSP-D – ligand complex. (a) The coordination of 
the calcium ion Ca1 and HepI (b) Stereo electron density for the bound Glc-Hep and the putative 
Kdo(anhydro) ligand. Original Kdo numbering retained. Density labelled A corresponds to the 
putative position of O2' (original Kdo numbering) in either or both of the enantiomeric 
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Figure 4. Formation of the 4,7 closure furanoid derivative (anhydro Kdo) following mild acid 
hydrolysis and β-elimination of the phosphate from O4 of Kdo. Original Kdo numbering retained. 
Adapted from (35). 
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Figure 5. The Hep-Kdo(anhydro) disaccharide in the ligand binding site. Kdo O6' is positioned to 
interact with Asp325, while the enantiomeric C4 substituent is not identifiable in the electron 
density except for an indication of O2' (original Kdo numbering), directed towards Arg343, which 
may be similarly positioned in both enantiomers. Original Kdo numbering retained. 
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